斋月禁食和血液学疾病:临床考虑,风险和管理策略
Abdulrahman Nasiri1, Ahmed Alahmadi2, Manal Alshammari3
1Imam Mohammad Ibn Saud Islamic University (IMSIU), College of medicine, Riyadh, Saudi Arabia.
Clinical hematology international
|December 15, 2025
概括
斋月禁食对患有贫血等血液疾病的患者构成风险. 高危人群应避免禁食,而稳定的患者可以在仔细规划和监测下安全地禁食.
科学领域:
- 血液学 血液学 血液学
- 内部医学 内部医学
- 宗教研究是宗教研究.
背景情况:
- 斋月禁食包括长时间减少水分和营养摄入量.
- 禁食期间的生理变化可能会影响具有先前血液状况的个体.
- 在血液病患者的斋月禁食现有的临床数据是有限的.
研究的目的:
- 审查斋月斋戒对患有血液学疾病的患者的潜在风险和益处.
- 为禁食血液病患者提供有关风险分层和管理策略的指导.
- 突出个性化护理和进一步研究的需要.
主要方法:
- 文献综述和临床专业知识综合.
- 在禁食期间与血液学条件相关的生理适应的分析.
- 开发一种基于风险的患者管理方法.
主要成果:
- 禁食可以加剧贫血,凝血病和恶性瘤等疾病.
- 高风险患者 (例如,接受化疗,移植后,严重贫血) 建议不要禁食.
- 稳定的血液病患者可以在斋月前进行评估,调整药物和严格的水分/营养计划后禁食.
结论:
- 个性化风险评估对于血液病患者安全斋戒至关重要.
- 患者和临床医生之间的共同决策至关重要.
- 需要进一步的研究,以建立基于证据的指导方针,为这个群体的斋月禁食.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
522
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
522
Hemodialysis III: Nursing Management
687
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
687
Hemodialysis II: Procedure and Complications
567
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
567
Peritoneal Dialysis III: Nursing Management
592
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
592
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235


